<DOC>
	<DOCNO>NCT01179308</DOCNO>
	<brief_summary>Test effect combine regiona/general anesthesia lung cancer recurrence compare general anesthesia alone .</brief_summary>
	<brief_title>Regional Anesthesia Lung Cancer Recurrence</brief_title>
	<detailed_description>Surgery primary treatment lung cancer , surgery release tumor cell systemic circulation . Whether minimal residual disease result clinical metastasis function host defense . At least three perioperative factor shift balance toward initiation progression minimal residual disease . ( 1 ) Surgery per se depress cell-mediated immunity , reduces concentration tumor-related anti-angiogenic factor ( e.g. , angiostatin endostatin ) , increase concentration pro-angiogenic factor VEGF . ( 2 ) Anesthesia impair numerous immune function , include neutrophil , macrophage , dendritic cell , T lymphocytes ( T-cell ) , Natural killer cell ( NK-cell ) function . ( 3 ) Opioid analgesic inhibit cellular humoral immune function human , promote tumor growth rodent . Regional analgesia attenuate adverse effect . For example , regional anesthesia largely prevent neuroendocrine stress response surgery block afferent neural transmission . With combined regional general anesthesia/analgesia , amount general anesthetic require much reduce â€” , presumably , immune suppression . And finally , regional analgesia provide superb pain relief , essentially obliterate need postoperative opioids . Animal study show regional anesthesia improve natural kill cell function reduce metastatic burden animal inoculate carcinoma cell . Preliminary retrospective data cancer patient show , paravertebral analgesia breast cancer surgery reduce risk recurrence metastasis 40 % 2.5 4-year follow-up period . The investigator thus propose evaluate effect combine epidural-general anesthesia compare general anesthesia cancer recurrence semi-annually period 5 year .</detailed_description>
	<mesh_term>Lung Neoplasms</mesh_term>
	<mesh_term>Recurrence</mesh_term>
	<mesh_term>Anesthetics</mesh_term>
	<criteria>Primary nonsmall cell lung cancer ( stage 13 ) determine accord IASLC Lung Cancer Staging Project ; Scheduled potentially curative tumor resection ; Written inform consent , include willingness randomize epidural anesthesia/analgesia plus general anesthesia general anesthesia postoperative opioid analgesia . Any contraindication epidural anesthesia , ( include coagulopathy , abnormal anatomy ) . Any contraindication midazolam , propofol , sevoflurane , fentanyl , morphine , hydromorphone . Age &lt; 18 &gt; 85 year old . Other cancer believe attend surgeon longterm remission .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>regional analgesia</keyword>
	<keyword>routine general anesthesia</keyword>
	<keyword>immune system response</keyword>
	<keyword>lung cancer ( stage 1-3 )</keyword>
</DOC>